Evidence map›Paper›PMID 40436991›Full record

ArticleScientific reports2025

Synthesis and characterization of cetylpyridinium peroxyphosphotungstate and their catalytic properties for linalool oxidation.

Shouji Zhu, Yingyi Chen, Ruoxin Zhou, Lishan Lin, Xinmei He, Jiayi Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shouji ZhuCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China. zsj82633829@126.com.
Yingyi ChenCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China.
Ruoxin ZhouCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China.
Lishan LinCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China.
Xinmei HeCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China.
Jiayi ZhangCollege of Chemical and Environmental Engineering, Hanshan Normal University, Chaozhou, 521041, Guangdong Province, China.

Funding

the Characteristic Innovation Project of Guangdong Colleges and Universities in 2022 2022KTSCX075
6 · The paper itself

Abstract

In this study, cetylpyridinium peroxyphosphotungstate was synthesized as an environmentally benign phase transfer catalyst with high catalytic activity from cetylpyridinium chloride, phosphotungstic acid, and hydrogen peroxide. The chemical structure of the catalyst was identified by SEM, XRD, FT-IR, ICP, elemental analysis, XPS, and TGA/DTG, revealing its catalytic activity to be related to the regular and dense distribution of pores on its surface. High catalytic activity was demonstrated in the oxidation of linalool to furanoid and pyranoid linalool oxides using hydrogen peroxide in low toxicity organic solvents such as ethanol and ethyl acetate. The total yield and total selectivity of furanoid and pyranoid linalool oxides were optimized by varying parameters including the catalyst loading, hydrogen peroxide amount, reaction temperature, and reaction time. Optimized conditions providing furanoid and pyranoid linalool oxides with 80.1% total yield were 10 wt% catalyst and 1.16 mL/g 30% H

Indexed as

CatalystCetylpyridinium peroxyphosphotungstateLinaloolLinalool oxideSynthesis

Identifiers

PMID40436991
PMCPMC12119997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.